Clinical Findings in Albanian Patients with 2009 Influenza AH1N1 Admitted at the Intensive Care Unit. (15th April 2014)

• Record Type: Journal Article
• Authors: Ndreu, Arben; Kraja, Dhimitër; Bino, Silva; Simaku, Artan; Hatibi, Iris; Çomo, Najada; Harxhi, Arjan; Ohri, Ilir; Shytaj, Kastriot; Kolovani, Entela; Sula, Hektor; Pilaca, Arben; Morrison, Shane; Rashidi, Vania; Mingomataj, Ervin Çerçiz
• Other Names: Chang C.-C. Academic Editor.; Karcioglu O. Academic Editor.
• Is Part Of: ISRN emergency medicine. Volume 2013(2013)
• Publication Date: 2014-04-15
• Subjects: Emergency medical services -- Periodicals; Emergency medicine -- Periodicals; Emergency Medicine; Emergency medical services; Emergency medicine; Electronic journals; Periodical; Periodicals; 616.025
• DOI: 10.1155/2013/914840
• Languages: English
• ISSNs: 2090-5629

Abstract

Abstract : Due to the ease of cross-continent spread of infectious diseases, the 2009 influenza AH1N1 (H1N1) affected many countries. This observational prospective study looked at Albanian patients admitted with 2009 H1N1 at the ICU of the Department of Infectious Diseases at the University Hospital Center of Tirana, from November 2009 to March 2010. Demographic data, symptoms, comorbidities, and clinical outcomes were collected from each patient. The number of days spent in the ICU was recorded for each patient along with their radiological and laboratory findings, and outcome at discharge. Critical illness occurred in 31 patients admitted with confirmed 2009 H1N1. The median age of patients was 35 years. Five (16.1%) patients required endotracheal intubation; noninvasive oxygen therapy (NIV) was used in 15 (48.4%) patients via nasal tube; and continuous positive airway pressure (CPAP) and pressure support ventilation (PSV) oxygen masks were used in 11 (35.5%) patients. All patients were treated with oseltamivir. Four patients admitted and treated did not survive. Critical illness in the setting of 2009 H1N1 admitted in the ICU predominantly affected young adults. NIV could play a role in treating 2009 influenza H1N1 infection-related hypoxemic respiratory failure that was associated with severe hypoxemia, pneumonia, requirement for prolonged mechanical ventilation, and the frequent use of antiviral therapy.